SCHEMBL8093530

SCHEMBL8093530

NC(=O)c1nc(Nc2ccc(OCc3ccccc3)cc2)c2c[c]ccc2n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT2 Q8IXJ6 1/20 0.50
EGFR P00533 6/20 0.47
ERBB2 P04626 5/20 0.47
AURKB Q96GD4 2/20 0.47
ERBB4 Q15303 2/20 0.47
CHEK2 O96017 1/20 0.47
ROS1 P08922 1/20 0.47
FLT3 P36888 1/20 0.47
CLK4 Q9HAZ1 1/20 0.47
MKNK2 Q9HBH9 1/20 0.47
TTBK1 Q5TCY1 1/20 0.45
TTBK2 Q6IQ55 1/20 0.45
PARP10 Q53GL7 1/20 0.44
LTA4H P09960 2/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
RAB9A P51151 3/20 0.43
LMNA P02545 1/20 0.43
POLB P06746 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8147977 0.86 SCN9A (0.50) EGFRERBB2TTBK1TTBK2MEN1
SCHEMBL4867050 0.77 EGFR (0.47) EGFRERBB2
SCHEMBL8081962 0.75 HCAR3 (0.39) EGFRERBB2LMNATP53SMN1; SMN2
SCHEMBL8488615 0.74 EGFR (0.42) EGFRERBB2ERBB4HDAC3HDAC4
SCHEMBL4886092 0.73 MAPT (0.51) MEN1KMT2ANPSR1SMN1; SMN2
SCHEMBL2991831 0.72 DYRK1A (0.47) EGFRERBB2
SCHEMBL8089906 0.72 SRD5A1 (0.44) EGFR
SCHEMBL4967279 0.70 MEN1 (0.60) CLK4MEN1KMT2ALMNAPOLB
SCHEMBL8093507 0.70 PARP1 (0.37) SIRT2MEN1KMT2ARAB9APOLB
SCHEMBL8900305 0.68 EGFR (0.69) EGFRERBB2AURKBERBB4CHEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6153617-A Irreversible bicyclic inhibitors of tyrosine kinases WARNER-LAMBERT COMPANY (US) 2000-11-28 US claimed
US-6127374-A AN ENZYME INHIBITOR FOR TREATING CANCER, RESTENOSIS, ATHEROSCLEROSIS, ENDOMETRIOSIS AND PSORIASIS WARNER-LAMBERT COMPANY (US) 2000-10-03 US claimed
WO-1999006396-A1 IRREVERSIBLE BICYCLIC INHIBITORS OF TYROSINE KINASES WARNER-LAMBERT COMPANY (US) 1999-02-11 WO claimed
WO-1999006378-A1 IRREVERSIBLE INHIBITORS OF TYROSINE KINASES WARNER-LAMBERT COMPANY (US) 1999-02-11 WO claimed
US-6153617-A Irreversible bicyclic inhibitors of tyrosine kinases WARNER-LAMBERT COMPANY (US) 2000-11-28 US disclosed
US-6127374-A AN ENZYME INHIBITOR FOR TREATING CANCER, RESTENOSIS, ATHEROSCLEROSIS, ENDOMETRIOSIS AND PSORIASIS WARNER-LAMBERT COMPANY (US) 2000-10-03 US disclosed
WO-1999006378-A1 IRREVERSIBLE INHIBITORS OF TYROSINE KINASES WARNER-LAMBERT COMPANY (US) 1999-02-11 WO disclosed
WO-1999006396-A1 IRREVERSIBLE BICYCLIC INHIBITORS OF TYROSINE KINASES WARNER-LAMBERT COMPANY (US) 1999-02-11 WO disclosed